 |
|
|
| Poster session 2: Drug resistance / Drug pharmacology |
| Date: | Saturday, June 12 2004 |
| Time: | 17:15-18:45 |
| Room: | |
| 17:15-18:45 |
517 |
|
|
ASSOCIATION OF MDR1 POLYMORPHISMS WITH DRUG RESISTANCE RISK IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS
O.B. Goreva, A.Y. Grishanova, O.V. Mukhin, N.P. Domnikova, V.V. Lyakhovich (Novosibirsk, Russian Federation)
| 17:15-18:45 |
518 |
|
|
EFFECTS OF IMATINIB MESYLATE ON NORMAL HAEMOPOIETIC PROGENITORS
J. Perez-Oteyza, M. Perez-Abad, P. Ramos, P. Herrera, M.L. Ramos, C. Montero, P. Gonzalez-Porque, J.L. Navarro (Madrid, Spain)
| 17:15-18:45 |
519 |
|
|
EFFECT OF DIOXIN ON HUMAN NORMAL HEMATOPOIETIC AND LEUKEMIC CELLS
G. Lambertenghi Deliliers, F. Servida, N. Fracchiolla, P.A. Bertazzi, D. Soligo (Milan, Italy)
| 17:15-18:45 |
520 |
|
|
DEVELOPMENT OF A NOVEL BIOSENSOR TO TO MONITOR ARA-C UPTAKE AND ASPECTS OF INTRACELLULAR METABOLISM BY AML CELLS
M.A. Smith, V.C. Salisbury, J.E. Angell, H.M. Alloush (Bristol, United Kingdom)
| 17:15-18:45 |
521 |
|
|
THE USE OF ANAGRELIDE FOR CONTROL OF THROMBOCYTHAEMIA
G.M. Benson, R. Desmond, E. Conneally, M.F. McMullin (Belfast, Northern Ireland)
| 17:15-18:45 |
522 |
|
|
SAFETY EXPERIENCE WITH TRISENOX® (ARSENIC TRIOXIDE) INJECTION
C. Oliva, B. Kirkhart, M.S. Maxon, R. Earhart (Bresso (milan), Italy)
| 17:15-18:45 |
523 |
|
|
INFLUENCE OF FUNCTIONAL POLYMORPHISM IN MDR1 GENE ON GENETIC PREDISPOSITION AND PROGNOSIS IN ADULT ACUTE LEUKEMIA
K. Jamroziak, E. Balcerczak, P. Smolewski, B. Cebula, M. Kowalczyk, M. Panczyk, M. Mirowski, W. Mlynarski, T. Robak (Lodz, Poland)
| 17:15-18:45 |
524 |
|
|
EXPRESSION OF THE MULTIDRUG RESISTANCE PROTEINS MDR1, MRP1 AND LRP IN RELATION TO DE NOVO ACUTE MYELOID LEUKEMIA TREATMENT OUTCOME
M. Podolak-Dawidziak, D. Dus, M. Kielbinski, M. Paprocka, M. Kuliszkiewicz-Janus, I. Prajs, K. Kuliczkowski (WrocŁaw, Poland)
| 17:15-18:45 |
525 |
|
|
THIOPURINE S-METHYLTRANSFERASE GENETIC VARIATION IN SERBIAN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
B. Petrucev, J. Urosevic, J. Poznanic, N. Tosic, L. Krivokapic Dokmanovic, D. Janic, S. Pavlovic (Belgrade, Serbia)
| 17:15-18:45 |
526 |
|
|
BIFOSFINIC PALLADACYCLE COMPLEX DERIVED FROM N,N-DIMETHYL-1-PHENETHYLAMINE AND THE LIGAND 1,1'BIS(DIPHENYLPHOSPHINE)FERROCENE INDUCES APOPTOSIS IN HL60 AND JURKAT CELL LINES IN THE PRESENCE OF NORMAL BCL-2 EXPRESSION.
C. Bincoletto, M.C.M. Smith, C.O. Rocha, G.Z. Justo, C.K. Matsumoto, A.C.F. Caires, R.C. Araújo (Mogi Das Cruzes, Brazil)
| 17:15-18:45 |
527 |
|
|
SNP MINING BY NANOGEN DEVICE: A SENSITIVE TOOL FOR THE IDENTIFICATION OF BCR/ABL MUTATIONS IN CHILDHOOD PH ALL
B. Corradi, R. Piazza, K. Monn, G. Masera, C. Gambacorti Passerini, A. Biondi, G. Cazzaniga (Monza, Italy)
| 17:15-18:45 |
528 |
|
|
CD80 AND CD38 EXPRESSION AND EX-VIVO CHEMOSENSITIVITY TO PURINE ANALOGUES IN CHRONIC LYMPHOCYTIC LEUKAEMIA
I. Del Giudice, A.G. Bosanquet, J. Durant, K. Owusu-Ankomah, A. Morilla, R. Morilla, E. Matutes, D. Catovsky (London, United Kingdom)
| 17:15-18:45 |
529 |
|
|
THE EXPRESSION OF MULTIDRUG RESISTANCE PROTEINS IN RELATION TO ZAP-70 EXPRESSION IN B-CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)
S. Narat, N.I. Folarin, R.J. Baker, D.T. Jones, S.M. Hart, R.G. Wickremasinghe, A.V. Hoffbrand, A.B. Mehta, K. Ganeshaguru (London, United Kingdom)
| 17:15-18:45 |
530 |
|
|
ANALYTICAL METHODOLOGY AND PHARMACOKINETICS OF CAMPATH-1H IN PATIENTS WITH CLL AFTER IV OR SC ADMINISTRATION
M. Montagna, M.A. Avanzini, M. Lazzarino, F. Locatelli, M. Montillo, C. Rusconi, E. Morra, M.B. Regazzi (Pavia, Italy)
| 17:15-18:45 |
531 |
|
|
TIME TO RESPONSE OF ASPERGILLUS ANTIGEN TO CASPOFUNGIN COMPARED TO AMPHOTERICINE B : A SMALL RETROSPECTIVE STUDY
H. De Samblanx, M. Van De Vyvere, A. Van Mechelen, P. Zachée (Antwerp, Belgium)
|